ThePMD

PSKW

PSKW is the innovation driver in biopharma loyalty marketing. We develop, execute, and manage (1) co-pay assistance initiatives using an array of tangible and virtual distribution channels, and (2) digital relationship tools that enhance physician/patient dialogue and help drive compliance and adherence. Co-Pay Assistance Initiatives: PSKW created the co-pay assistance industry and ...
 

PDQ Communications, Inc.

PDQ Communications is a healthcare communications company, assisting pharmaceutical manufacturers and others to update healthcare professionals with product information in a timely manner. PDQ MAIL aids the pharmaceutical manufacturer by delivering their message to healthcare providers in all practice settings. Custom mailings feature FLASH branding and are targeted to the ...
 

DMD

DMD, a digital healthcare intelligence company, brings clarity to data overload in the fast-moving practice of marketing to healthcare professionals. DMD enables healthcare marketers to build ongoing relationships with HCPs via a uniquely sourced, micro-targeted, cross-channel database. Using robust email analytics and email asset optimization in a consultative partnership with ...
 

Subscribe today

 

Over 25,000 healthcare contacts at your fingertips

Get full online access and a copy of The PMD in print. 

Click for more information »

PMD ReFresh

High Climber

Gregg Fisher, founder and managing partner, The Stem
 

Workspace

James Hyde-Dunn, VP, business development, Cello Health
 

More from ReFresh

Click here to sign up for the latest ReFresh, PMD's monthly newsletter update

Latest from MM&M

Five things for pharma marketers to know: Wednesday, August 19

Sprout's controversial sexual-desire drug receives FDA approval; prescription-drug coverage impacts cash sales at Walmart; Mylan warned about manufacturing violations
 

Amgen settles off-label case with states

State attorneys general accused the drugmaker of violating state consumer protection laws.
 

Five things for pharma marketers to know: Tuesday, August 18

Biogen to map ALS genes with Ice Bucket Challenge funds; Merck seeks first-line indication for Keytruda; lawmaker criticizes FDA approval of OxyContin for children